Abbvie To Invest $380 Million In North Chicago To Further Expand Active Pharmaceutical Ingredient Manufacturing In The United States

Investment marks continued progress against AbbVie's $100 billion commitment to U.S. research and development (R&D) and capital investments, including manufacturing, over the next decade Two new facilities will be built to add advanced manufacturing ...Read more